Avacta Appoints Patrick Vink as Deputy Chairman and Senior Independent Director

Management
โดย RTTNews·Read original
Summary · why it matters

Avacta Group Plc has appointed Patrick Vink as Non-Executive Deputy Chairman and Senior Independent Director to its Board of Directors. Vink currently serves as Chairman at Arch Biopartners Inc and is a board member of Spero Therapeutics Inc, where he chairs the Nominating and Corporate Governance Committee. He also chairs three privately held companies: Micreos Group, Secura Bio Inc, and F2G Ltd. Previously, Vink was Executive Vice-President and Chief Operating Officer at Cubist Pharmaceuticals Inc and a member of the Executive Committee of the European Federation of Pharmaceutical Industries and Associations between 2013 and 2015. Avacta's shares were trading down 1.63% to 69.35 pounds on the London Stock Exchange.

Impact on stocks 2

Health Care▲ · 2 stocks
Avacta Group PLC
AVCT
± MixedCapitalrelevance

Appointment of a new board member with industry experience, but no immediate operational or financial impact stated.

Off-coverage companies 4

Arch Biopartners IncPrivate± Mixed
relevance

F2G LtdPrivate± Mixed
relevance

Micreos GroupPrivate± Mixed
relevance

Secura Bio, Inc.Private± Mixed
relevance

© 2026 MarketDXNews